comparemela.com

Latest Breaking News On - News ratings for actinium pharmaceuticals daily - Page 1 : comparemela.com

Actinium Pharmaceuticals, Inc (NYSEAMERICAN:ATNM) Given Consensus Recommendation of Buy by Brokerages

Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Get Free Report) has been assigned a consensus rating of “Buy” from the six analysts that are covering the company, MarketBeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average twelve-month target price among brokers that have issued a report on the stock in […]

Actinium Pharmaceuticals, Inc (NYSEAMERICAN:ATNM) Receives $25 60 Consensus Target Price from Analysts

Shares of Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Get Free Report) have earned an average rating of “Buy” from the six brokerages that are presently covering the firm, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation. The average 1 year target price among brokers that have covered the stock […]

HC Wainwright Reaffirms Buy Rating for Actinium Pharmaceuticals (NYSEAMERICAN:ATNM)

HC Wainwright reiterated their buy rating on shares of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM – Free Report) in a research note issued to investors on Tuesday morning, Benzinga reports. HC Wainwright currently has a $50.00 target price on the biotechnology company’s stock. Several other research analysts also recently commented on ATNM. Cantor Fitzgerald reaffirmed an overweight rating […]

Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) Rating Reiterated by HC Wainwright

HC Wainwright reiterated their buy rating on shares of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM – Free Report) in a report published on Tuesday morning, Benzinga reports. The brokerage currently has a $50.00 target price on the biotechnology company’s stock. Other analysts have also recently issued reports about the stock. Stephens initiated coverage on shares of Actinium Pharmaceuticals […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.